Discounted Cash Flow

Acadia Healthcare Company, Inc.

ACHC · Based on 10 years of SEC filings

DCF estimate unavailable — only_6_profitable_out_of_10

Average annual growth rates

Metric 10-Year 5-Year 3-Year
Sales
Free Cash Flow
Average (FCF & NI)
Net Income

Average annual growth is the mean year-over-year change across each period.

Endpoint CAGR (better for long term trend)

Metric 10-Year 5-Year 3-Year
Sales
Free Cash Flow
Average (FCF & NI)
Net Income

Endpoint CAGR is the compound annual rate from the first to last year in each period.

Projections use average year-over-year growth. Change this in Settings.

Projected growth rate

Free cash flow growth
10-year: — 5-year: — 3-year: —
Averaged growth (FCF & NI)
10-year: — 5-year: — 3-year: —
Net income growth
10-year: — 5-year: — 3-year: —
Sales growth (not added to calculations)
10-year: — 5-year: — 3-year: —

Click a greyed-out slider to switch metrics. Slide between the 10-year, 5-year, and 3-year historic growth rates for FCF, net income, or their average.

%
%

Historical inputs (10 fiscal years)

YEAR Sales Net Income Free Cash Flow Net Margin EPS (diluted)
2016 $-181.3m $6.1m $54.0m -3.4% $0.07
2017 $-176.0m (2.9%) $199.8m (3153.1%) $125.4m (132.2%) -113.5% (-3251.3%) $2.30 (3185.7%)
2018 $3.0b (1811.5%) $-175.8m (-187.9%) $72.6m (-42.1%) -5.8% (94.9%) $-2.01 (-187.4%)
2019 $3.1b (3.2%) $108.9m (162.0%) $48.2m (-33.6%) 3.5% (160.1%) $1.24 (161.7%)
2020 $2.1b (-32.7%) $-672.1m (-717.1%) $442.2m (817.0%) -32.2% (-1017.5%) $-7.65 (-716.9%)
2021 $2.3b (10.7%) $190.6m (128.4%) $129.7m (-70.7%) 8.2% (125.6%) $2.15 (128.1%)
2022 $2.6b (12.8%) $273.1m (43.3%) $84.4m (-34.9%) 10.5% (27.0%) $3.05 (41.9%)
2023 $2.9b (12.2%) $-21.7m (-107.9%) $38.2m (-54.7%) -0.7% (-107.1%) $-0.24 (-107.9%)
2024 $3.2b (7.7%) $255.6m (1279.7%) $-560.7m (-1567.5%) 8.1% (1195.5%) $2.79 (1262.5%)
2025 $3.3b (5.0%) $-1.1b (-531.4%) $-439.9m (21.5%) -33.3% (-510.7%) $-12.16 (-535.8%)

Base FCF: (latest fiscal year)

Discount rate: %

Terminal growth:

Projection period: years

Alt A decline yrs:

Alt B total yrs:

Values abbreviated: b = billions, m = millions, k = thousands.

Projected cash flows

Year Projected cash flow Discount Factor Present Value

PV of projected FCF:

Terminal FCF:

Terminal value:

PV of terminal value:

Enterprise value (DCF):

DCF price per share:

Current price:

Alternative DCF Models

Model Fair Value Upside PV(FCFs) PV(Terminal) Total Years
Standard (10yr→TV) 10 + TV
Alt A (Gradual Decline)
Alt B (30yr Hard Stop) N/A

This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.

+ 10YR Financials Balance Sheet (10YR) Cash Flow (10YR) DCF Model

only_6_profitable_out_of_10

Once the company meets all DCF eligibility criteria (sufficient history, profitability, growth trends), an estimate will become available automatically. No action is needed.